Sarepta Therapeutics' (SRPT) "Overweight" Rating Reiterated at JPMorgan Chase & Co

Lloyd Doyle
February 25, 2018

Snyder Capital Management LP sold 75,029 shares as the company's stock declined 0.66% while stock markets rallied. The stock has a market cap of $4,190.00, a price-to-earnings ratio of -31.33 and a beta of 1.49. The stock increased 1.29% or $1.59 during the last trading session, reaching $125. Paychex, Inc. (NASDAQ:PAYX) has risen 11.22% since February 25, 2017 and is uptrending. It has underperformed by 47.98% the S&P500. It also increased its holding in United Cmnty Bks Blairsvle G (NASDAQ:UCBI) by 240,003 shares in the quarter, for a total of 895,187 shares, and has risen its stake in Valmont Inds Inc (NYSE:VMI). Sectoral Asset Management Inc bought 40,300 shares as the company's stock rose 22.49% with the market. Following the completion of the transaction, the director now owns 13,333 shares in the company, valued at approximately $745,181.37. Sarepta Therapeutics has a fifty-two week low of $28.14 and a fifty-two week high of $68.90. The stock increased 1.23% or $0.57 during the last trading session, reaching $46.77. About 317,810 shares traded.

Sarepta Therapeutics (SRPT) opened at $63.91 on Friday. It has outperformed by 20.71% the S&P500.

Investors sentiment decreased to 1.06 in 2017 Q3. Its up 0.30, from 0.63 in 2017Q2. It dropped, as 42 investors sold THO shares while 139 reduced holdings. 166.73 million shares or 50.62% less from 337.64 million shares in 2017Q2 were reported. Nomura Holdg reported 423,983 shares or 0.04% of all its holdings. Moreover, Bokf Na has 0.08% invested in Thor Industries, Inc. Bessemer Grp invested 0.01% in Paychex, Inc. (NYSE:THO) has "Buy" rating given on Friday, June 9 by Citigroup. Stonebridge Cap Mngmt Inc accumulated 5,835 shares. 1,700 were accumulated by Nine Chapters Cap Limited Liability Corporation. Ronna Sue Cohen holds 45,825 shares. Baxter Bros holds 1.71% or 99,315 shares. (NASDAQ:PAYX) for 35,124 shares.

Among 14 analysts covering Thor Industries Inc (NYSE:THO), 7 have Buy rating, 0 Sell and 7 Hold. Therefore 6% are positive.

SRPT has been the subject of a number of analyst reports. The firm has "Hold" rating by Zacks given on Friday, September 4. American Century Companies reported 72,394 shares. The rating was maintained by Compass Point on Thursday, December 22 with "Sell". RBC Capital Markets maintained Paychex, Inc. Roth Capital maintained the stock with "Buy" rating in Wednesday, November 11 report. Oppenheimer reiterated a "buy" rating and issued a $76.00 target price on shares of Sarepta Therapeutics in a report on Monday, October 16th. RBC Capital Markets has "Underperform" rating and $54 target. (NASDAQ:SRPT) for 44,863 shares. Robert W. Baird maintained the stock with "Outperform" rating in Monday, September 19 report. The firm has "Buy" rating given on Tuesday, February 6 by RBC Capital Markets. Inc. purchased a new position in shares of Sarepta Therapeutics in the 4th quarter valued at about $199,000.

Since September 28, 2017, it had 0 insider buys, and 3 insider sales for $15.31 million activity. (NASDAQ:PAYX) on Friday, October 6. (NYSE:TWX) was sold by WRIGHT DEBORAH C. The insider BARR WILLIAM P sold 4,019 shares worth $390,647. On Thursday, October 5 MUCCI MARTIN sold $1.88 million worth of Paychex, Inc. (NASDAQ:PAYX) or 29,786 shares. Therefore 81% are positive. Zosano Pharma had 5 analyst reports since September 29, 2015 according to SRatingsIntel. The firm has "Outperform" rating given on Thursday, March 2 by Leerink Swann. As per Friday, October 20, the company rating was maintained by Citigroup. As per Wednesday, September 28, the company rating was upgraded by Wellington Shields. The stock of Thor Industries, Inc. BlackRock Inc. increased its holdings in shares of Sarepta Therapeutics by 0.9% in the 4th quarter. The firm has "Neutral" rating by SunTrust given on Tuesday, September 1. The stock has "Equal-Weight" rating by Morgan Stanley on Thursday, July 20. The firm has "Market Perform" rating given on Tuesday, January 3 by Telsey Advisory Group. The company was downgraded on Tuesday, July 26 by FBR Capital. The company was maintained on Wednesday, November 22 by BMO Capital Markets.

Other hedge funds and other institutional investors also recently made changes to their positions in the company.

Investors sentiment increased to 2.88 in 2017 Q3.

Want to see what other hedge funds are holding SRPT? 58 funds opened positions while 95 raised stakes.

Pura Vida Investments Llc decreased Envision Healthcare Corp stake by 64,008 shares to 123,192 valued at $5.54 billion in 2017Q3. Ameriprise Incorporated stated it has 0.01% of its portfolio in Copart, Inc. (NASDAQ:SRPT) for 170,140 shares. Thompson Davis Com owns 121 shares. Benjamin F Edwards Co Inc reported 0% stake. 339,674 are held by Citadel Advsr Ltd Limited Liability Company. Moreover, Hanson Mcclain has 0% invested in Sarepta Therapeutics, Inc. (NASDAQ:SRPT) for 142,900 shares. (NASDAQ:CPRT). Nuveen Asset Management Ltd Liability invested 0% in Copart, Inc.

JPMorgan Chase & Co. restated their overweight rating on shares of Sarepta Therapeutics (NASDAQ:SRPT) in a research note issued to investors on Wednesday. Amer Int Group stated it has 0.01% in Sarepta Therapeutics, Inc. (NASDAQ:SRPT) or 250,000 shares. Ahl Llp holds 0.06% or 13,984 shares in its portfolio.

Since October 3, 2017, it had 0 buys, and 1 insider sale for $575,000 activity.

- Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Other reports by Iphone Fresh

Discuss This Article